The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Imfinzi-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage...
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.AstraZenec...
"AstraZeneca Sees Challenging Times Ahead,"Chemist & Druggist, February 17, 2001, p. 24. "AstraZeneca's Poor Performance in UK,"Chemist & Druggist, August 5, 2000, p. 24. Barrett, Amy and Kerry Capell, "Prilosec Time Is Just About Up,"Business Week, January 8, 2001, p. 47. Bennet...
InOctober 2024, AstraZeneca entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance the development of an early stage, novel small molecule Lipoprotein (a) (Lp(a)) disruptor that has the potential to offer additional benefits for patients with dyslipid...
AstraZeneca AstraZeneca PLC Public LSE, NYSE and OMX: AZNFounded6 April 1999 by mergerHeadquartersLondon, England, UKKey peopleDavid Brennan CEOTony Zook
AstraZenecais a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based inCambridge, UK,A...
AstraZeneca PLC (London, UK, www.astrazeneca.com) has announced the resignation of its CFO Jon Symonds, at the end of July. Symonds joined Zeneca in 1997 as CFO after 17 years at KPMG. AstraZeneca PLC (London, UK, www.astrazeneca.com) has announced the resignation of its CFO Jon ...
and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visitastrazeneca.comand follow the Company on social med...
and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by mil...
AstraZeneca has its corporate headquarters in Cambridge, United Kingdom, and its main research and development (R&D) centers are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden), and Warsaw (Poland). Moderator for this webinar is Mr. Peter Ling-Vannerus, Chie...